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The Cyssor reagent, 2-methyl-Nt-benzenesulfonyl-N4-bromoacetylqu~onedi~de, which 
will cleave a protein chain at Cys under acidic conditions, cross-linked unreduced and partially 
reduced antibody at pH 8.0. No cleavage of the antibody occurred suggesting that the Cyssor 
reagent may be useful with certain proteins as a heterobifunctional cross-linker. 0 1989 Academic 
We report the use of the Cyssor reagent (1,2,3) 2-methyl-N1-benzenesulfonyl-N4- 
bromoacetylquinonediimide [Scheme 1, 21, for the attempted cleavage of a partially reduced 
monoclonal antibody. Partial reduction of an antibody generally breaks disulfide bridges in the 
hinge region of an antibody (4). This is a region often targeted by proteases for producing 
antibody fragments still capable of binding antigen. Since the Cyssor reagent is released from the 
fragment during cleavage [Scheme 1,l --> 6a + 6b], it was our intent to produce a new type of 
antibody fragment different from those produced by the classical pepsin (5) and papain (6) 
digestions. Instead of fragmentation, we observed cross-linking of the antibody by Cyssor reagent 
with both unreduced (control) as well as partially reduced (experimental) antibody. 
MATERIALS AND METHODS 
B6.2, a mouse anti human tumor monoclonal IgGl (7,8), (hybridoma cells supplied by Dr. 
J. Schlom, N.C.I.) was purified by 50% (NH,)SO, precipitation and cation exchange 
chromatography utilizing the Pharmacia FPLC system and a Mono S column (9). Purity was 
assessed on a DuPont GF250 gel permeation HPLC column and on 5-15% polyacrylamide discing 
SDS gels (10). Spectrophotometric measurements were used to quantitate antibody concentration 
using E = 1.89 at 0.1% protein, 280 nm, based on amino acid analysis. The antibody, 1-3 mg/ml, 
in 0.1 M Na phosphate buffer, pH 8.0,2 mM EDTA, was partially reduced by the addition of 0.05 
M 2-mercaptoethanol followed by 45 min incubation at 37*C. Excess reductant was removed by 
G-25 Sephadex gel filtration on a 1 x 40 cm column loading l-2 ml, collecting 1.5 ml/fraction. 
ABBREVIATIONS 
Cyssor, 2-methyl-N1 benzenesulfonyl-N4-bromoacetylquinonediimide; SDS, sodium 
dodecylsulfate. 
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Sulfhydryl groups in the partially reduced antibody were quantitated with 2,2’-dithiodipyridine 
(AldrithiolTM-2 from Aldrich) using E = 7,600 l/M at 343 nm (11,12). 
The Cyssor reagent was purchased from the Sigma Chemical Company, lot 87C 0380, 
(structure confirmed by 1H NMR in d6MezSO) and dissolved (2.5 mg/ml) in Me$O (Pierce 
Chemical Company, Sequanal grade) prior to addition to the antibody. 
Modification reactions were performed in 0.1 M Na phosphate buffer, pH 8.0, 2 mM 
EDTA at about 1.0 mg/ml antibody, using a 10 mol excess of Cyssor reagent, adding 10 pi/ml of 
antibody solution. Reactions were carried out overnight at XPC. 
Modified antibody samples were analyzed for inter- and intramolecular cross-linking under 
denaturing conditions on 515% polyacrylamide-SDS discing gels (10) under both reducing and 
nonreducing conditions using about 25 pg of protein per lane. The samples were boiled 3 min 
prior to electrophoresis. 
Intermolecular cross-linking of antibody was determined for native protein by gel 
permeation on a DuPont GF250 I-IPLC column. The eluant was 0.2 M Na phosphate buffer, pH 
7.0. Protein was monitored by absorption at 280 nm. The absorption peaks were quantitated with 
a Spectra-Physics 4200 integrator-recorder. 
RESULTS 
Antibodv Partial Reduction 
The reduction conditions for B6.2 monoclonal antibody generated about 10 mol of 
sulfhydryllmol antibody. 
Intermolecular Cross-Linking - Native Conditions 
A gel permeation HPLC (native conditions) comparison of both unreduced (Fig. 1A) and 
partially reduced antibody (Fig. 1B) with the untreated control (Fig. 1C) indicated the presence of 
intermolecularly cross-linked antibody. Higher levels of interantibody cross-linking were evident 
for unreduced antibody (6.8%) than for the partially reduced antibody (2.5%). The Me2SO treated 
control did not show even a trace of interantibody cross-linking. Clearly there was no evidence of 
cleavage of the antibody into Fc and either F(ab’)z or Fab’s. The large peak at 12 minutes in the 
chromatogram represents a contaminant present in the EDTA used in the reaction buffer. The tiny 
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FIGURE 1. A - Size exclusion HPLC of unreduced antibody (1Ocg) with Me2SO (5%) and 
Cyssor reagent at a 10 mol excess. Peak 1, antibody intermolecularly cross-linked; peak 2, 
monomeric antibody, peak 3, buffer contaminant. Other chromatography conditions as described 
in the Materials and Methods. B - Partially reduced antibody (1OFg) with Me2SO and a 10 mol 
excess of Cyssor reagent. C - Unreduced antibody control (l@g) with MezSO (5%) and no 
Cyssor reagent. No intermolecularly cross-linked antibody present. 
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SDS 515% polyacylamide gel electrophosesis done under non-reducing conditions; Figure 2, or 
reducing conditions; Figure 3. Lanes 1 and 10, low and high molecular mass standards which 
were supplied by Bio-Rad and consisted of lysozyme, 14,400 Da; soybean trypsin inhibitor, 
21,500 Da; carbonic anhydrase, 31,000 Da; ovalbumin, 45,000 Da; bovine serum albumin, 
66,200 Da; phosphorylase B, 92,500 Da; for low molecular mass and the latter three plus B- 
galactosidase, 116,250 Da; and myosin, 200,000 Da for high molecular mass; lane 3, unreduced 
antibody (25pg}, treated with 5% Me$O, no Cyssor; lane 5, unreduced antibody (25l.tg) treated 
with 5% MezSO and a IO mol excess of Cyssor; lane 7, partially reduced antibody (25pg), treated 
with 5% Me2SO and a 10 mol excess of Cyssor. 
conditions described in the Materials and Methods. 
Sample preparation and electrophoresis 
Inter and Intramolecular Cross-Linking Under Denaturine Conditions 
SDS gel ekctrophoresis under nonreducing conditions did not reveal any evidence of 
interantibody cross-linking for antibody treated with MezSO only (Fig. 2, Lane 3). Interantibody 
cross-linking was, however, clearly evident for the unreduced antibody treated with the Cyssor 
reagent, (Fig. 2 Lane 5). Somewhat less interantibody cross-linking was evident for the partially 
reduced antibody treated with the Cyssor reagent (Fig. 2, Lane 7). 
The lower molecular mass bands observed in Fig. 2, Lane 7, were attributed to the partial 
reduction of the antibody rather than Cyssor induced cleavage. Had such cleavage occurred it 
should have been evident also on the sample electrophoresed under reducing conditions (Fig. 3, 
Lane 7) and clearly was not. 
SDS-polyacrylamide gel eleetrophoresis under reducing conditions did not reveal any 
evidence of intraantibody or interantibody cross-linking for the unreduced antibody treated with 
Me2SO only (Fig. 3, Lane 3). Intramolecular cross-linking and traces of intermolecular cross- 
linking were evident for unreduced antibody treated with the Cyssor reagent (Fig. 3, Lane 5). 
Finally, partially reduced antibody treated with Cyssor reagent clearly showed evidence of 
significant interantibody as well as intrantibody cross-linking.( Fig. 3, Lane 7). 
Other than the expected heavy and light chain protein bands of 50,ooO and 25,ooO Da, no 
other bands of less than 50,000 Da were evident. Cyssor induced cIeavage did not appear to have 
Qccurreti. 
Ovalbumin, which has free sulfhydryl groups, was cross-linked by the Cyssor reagent 
under the conditions described in the Materials and Methods. A diffuse stained band at about 
90,000 Da was seen on SDS gels (data not shown). Also, ovalbumin was readily cleaved by the 
same lot of Cyssor reagent under acidic conditions after WC incubation as described in (1). 
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DISCUSSION 
Partial reduction of a mouse monoclonal IgG has been shown to reduce preferentially the 
disulfide bridges in the hinge region making them available for chemical modification by sulfhydryl 
modifying reagents (6, 13). Our objective was to see if the cysteine sites afforded by the reduction 
of the cystine S-S bonds could be used as cleavage points on the antibody structure [Scheme 1.3 - 
-> 7 or 3 --> 6u + 6b]. Since the Cyssor reagent is a bis alkylating agent it is not surprising to find 
recross-linking of the reduced cystines rather than cleavage because of their close proximity 
[Scheme 1, 3 --> 7 or 3 --> 81. The nature of the cross-linking interaction remains obscure 
however, since there is little change in the amino acid composition of the antibody (data not 
shown). 
Dehydroalanine residues [Scheme 1,6], intermediates in the fragmentation process, can be 
formed from interaction of the Cyssor reagent with cysteine and this dehydroalanine residue can 
interact subsequently with another cysteine to form lanthionine cross-links [Scheme 1,6 --> 7]. 
Alternately, intermediate 4 can be intercepted by a cysteine residue to yield Cyssor cross-linked 
cysteines [Scheme 1, 3 --> 4 --> 81. Thus, on amino acid analysis we anticipated either the 
formation of carboxymethylcysteine (from 8), lanthionine (from 7) or at least the loss of cysteine 
SCHEME 1 
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residues (from 6) in the amino acid analysis. None of these were observed. Appparently there is 
sufficient interaction of the Cyssor reagent with other functions of the antibody chains to preclude 
these paths. Suggested alternatives are that the cross-linking is taking place between residues for 
which amino acid analysis is not sensitive or that the conditions of hydrolysis release the linker 
from the attachment sites (or both). Residues which are likely candidates are tryptophan or aspartic 
and glutamic acids. Tryptophan is known to interact with the Cyssor reagent through 
quinoneimine addition to the indole 8 position [Scheme 2,9 --> 10 --> II] and alkylation of the 
indole residue with the bromoacetyl function is also known. Alternatively, aspartic and glutamic 
residues can act as nucleophiles for additions to the quinoneimine portion of the reagent to give 
phenol esters and carboxyl groups can as well displace the bromine of the bromoacetyl residue 
[Scheme 2, I2 --> 13 --> 141. The ester links would hydrolyze easily under the acidic digestion of 
the protein yet would still give cross-links stable to reduction. Such cross-linking interactions 
seem dubious in a competition against SH groups but specific domain associations of the Cyssor 
reagent may enhance this chemistry. 
While we report on Cyssor cross-linking at pH 8.0 in this study, we have observed cross- 
linking activity from pH 4.0-8.0 with the levels dropping with the pH for both unreduced and 
partially reduced antibody. Me$O induced precipitation of the antibody precluded HPLC analyses 
of the pH 4.0 samples. No Cyssor induced antibody cleavage was observed under any of the 
experimental conditions described in this study. The cross-linking activity of the Cyssor reagent at 
neutral pH under mild conditions gives protein chemists another path for cross-linking. 
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